Titan Pharmaceuticals, Inc.
IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCES
Last updated:
Abstract:
Implants are described which comprise lipophilic pharmaceutical substances. Excipients are used which provide appropriate and controllable/tunable release of the lipophilic drug from the matrix of the implant. The implants can be implanted into a patient for release of the pharmaceutical substances. Methods of making and using such implants are also described.
Status:
Application
Type:
Utility
Filling date:
25 Jun 2019
Issue date:
22 Apr 2021